Target intelligence / Profile preview

Novel transcript, antisense to ALOX12B (ENSG00000214999)

Target
ENSG00000214999
Molecular classification
Long non-coding RNA (lncRNA), Other (non-coding RNA, regulatory RNA)
01

Overview

This target is a **long non-coding RNA (lncRNA)** transcribed antisense to the *ALOX12B* gene. It does not encode a protein but may participate in the regulation of the ALOX12B gene through an antisense-sense RNA duplex mechanism. The functional significance of this lncRNA remains largely uncharacterized, although similar antisense lncRNAs have been implicated in regulating gene expression post-transcriptionally or epigenetically[1][3][5]. There are no reports of this transcript itself acting as a drug target, biomarker, or disease gene, though such non-coding RNAs can play important regulatory roles in specific tissues or disease contexts. If structured information is required, there are currently no established drug interactions, therapeutic roles, or validated biomarker uses for this specific transcript, and its functional characterization is incomplete. However, it is correctly annotated as a genomic regulatory element with a likely role in modulating the expression of its sense counterpart, ALOX12B.

Other names
AC129492.6novel transcript antisense to ALOX12BLOC130060127
02

Biological functions

Gene expression regulationPossible translational interference or regulatory function on the sense ALOX12B transcriptOther (no direct role as a protein or enzyme)
03

Disease associations

Other (no established direct disease roles, but association studies may exist for lncRNAs in general regulation)

Beyond the preview

Go deeper on Novel transcript, antisense to ALOX12B (ENSG00000214999).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to ALOX12B (ENSG00000214999).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call